Association of Afamelanotide With Improved Outcomes in Patients With Erythropoietic Protoporphyria in Clinical Practice

IMPORTANCE: The effectiveness of afamelanotide treatment in patients with erythropoietic protoporphyria (EPP) in clinical practice who experience pain after light exposure that substantially impairs quality of life is unknown. OBJECTIVE: To evaluate the association of afamelanotide treatment with ou...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Dermatol
Main Authors: Wensink, Debby, Wagenmakers, Margreet A. E. M., Barman-Aksözen, Jasmin, Friesema, Edith C. H., Wilson, J. H. Paul, van Rosmalen, Joost, Langendonk, Janneke G.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Brief Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7081144/
https://ncbi.nlm.nih.gov/pubmed/32186677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2020.0352
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares